Snell V - Search Results

1

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival.

Zheng B, Fiumara P, Li YV, Georgakis G, Snell V, Younes M, Vauthey JN, Carbone A, Younes A. Zheng B, et al. Among authors: snell v. Blood. 2003 Aug 1;102(3):1019-27. doi: 10.1182/blood-2002-11-3507. Epub 2003 Apr 10. Blood. 2003. PMID: 12689928 Free article.

2

Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.

Fiumara P, Snell V, Li Y, Mukhopadhyay A, Younes M, Gillenwater AM, Cabanillas F, Aggarwal BB, Younes A. Fiumara P, et al. Among authors: snell v. Blood. 2001 Nov 1;98(9):2784-90. doi: 10.1182/blood.v98.9.2784. Blood. 2001. PMID: 11675352 Free article.

3

CD30-ligand and CD40-ligand expression in lymph nodes involved with Hodgkin's disease.

Younes A, Zhao S, Zhang X, Snell V, Clodi K, Kliche KO, Thomas E, Cabanillas F, Andreeff M. Younes A, et al. Among authors: snell v. Ann Oncol. 1997;8 Suppl 2:97-100. Ann Oncol. 1997. PMID: 9209650

4

Unbalanced expression of Fas and CD40 in mantle cell lymphoma.

Clodi K, Snell V, Zhao S, Cabanillas F, Andreeff M, Younes A. Clodi K, et al. Among authors: snell v. Br J Haematol. 1998 Oct;103(1):217-9. doi: 10.1046/j.1365-2141.1998.00958.x. Br J Haematol. 1998. PMID: 9792311 Free article.

5

Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies.

Snell V, Clodi K, Zhao S, Goodwin R, Thomas EK, Morris SW, Kadin ME, Cabanillas F, Andreeff M, Younes A. Snell V, et al. Br J Haematol. 1997 Dec;99(3):618-24. doi: 10.1046/j.1365-2141.1997.4393250.x. Br J Haematol. 1997. PMID: 9401075 Free article.

6

Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia.

Younes A, Snell V, Consoli U, Clodi K, Zhao S, Palmer JL, Thomas EK, Armitage RJ, Andreeff M. Younes A, et al. Among authors: snell v. Br J Haematol. 1998 Jan;100(1):135-41. doi: 10.1046/j.1365-2141.1998.00522.x. Br J Haematol. 1998. PMID: 9450802 Free article.

7

CD30 ligand is expressed on resting normal and malignant human B lymphocytes.

Younes A, Consoli U, Zhao S, Snell V, Thomas E, Gruss HJ, Cabanillas F, Andreeff M. Younes A, et al. Among authors: snell v. Br J Haematol. 1996 Jun;93(3):569-71. doi: 10.1046/j.1365-2141.1996.d01-1686.x. Br J Haematol. 1996. PMID: 8652374

8

CD30 ligand in lymphoma patients with CD30+ tumors.

Younes A, Consoli U, Snell V, Clodi K, Kliche KO, Palmer JL, Gruss HJ, Armitage R, Thomas EK, Cabanillas F, Andreeff M. Younes A, et al. Among authors: snell v. J Clin Oncol. 1997 Nov;15(11):3355-62. doi: 10.1200/JCO.1997.15.11.3355. J Clin Oncol. 1997. PMID: 9363866 Clinical Trial.

9

Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.

Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M. Lisovsky M, et al. Among authors: snell v. Blood. 1996 Nov 15;88(10):3987-97. Blood. 1996. PMID: 8916965 Free article.

10

Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia.

Consoli U, El-Tounsi I, Sandoval A, Snell V, Kleine HD, Brown W, Robinson JR, DiRaimondo F, Plunkett W, Andreeff M. Consoli U, et al. Among authors: snell v. Blood. 1998 Mar 1;91(5):1742-8. Blood. 1998. PMID: 9473241 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters